Genbioma
Genbioma (Genbioma Aplicaciones S.L.) is a Navarra-based biotech company founded in June 2019 as a spin-off of the Public University of Navarra (UPNA) that turns microbiome science into clinically validated probiotic and postbiotic ingredients for metabolic health. Its lead product, the postbiotic pA1c®HI (based on the proprietary Pediococcus acidilactici pA1c® strain), targets glucose control, pre-diabetes and type 2 diabetes and is backed by 11+ preclinical studies, two human clinical trials and two patent families. The company raised a €525,000 seed round in February 2025 from Clave Capital (via its UN I+D+i Tech Transfer and Navarra Tech Transfer funds) and the WA4STEAM women's angel network, and was named most innovative startup of Navarra at the EmprendeXXI Awards. It is headquartered in Noáin/Pamplona (Navarra).
Founders
Global models 3
P
S
TIn the same niche 26 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 2
Open as list →
Funding rounds 3
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-02-11 | Seed (estimated) | €525K |
Clave Capital
+1 more
|
| 2021-01-26 | Pre-seed (estimated) | €400K | Clave |
| 2020-02-06 | Pre-seed | — |
Lead not disclosed
+1 more
|
News 3
Open as list →| Published | Article |
|---|---|
| 2025-09-08 |
Genbioma builds science and market for pro- and postbiotic's metabolic potential ↗
NutraIngredients
2025-09-08 |
| 2025-02-11 |
Genbioma Aplicaciones cierra una inyección de €525.000 por parte de Clave Capital y la red de inversoras WA4STEAM ↗
Capital-Riesgo.es
2025-02-11 |
| 2023-04-17 |
Genbioma, was recognized as the most innovative startup at the EmprendeXXI Awards ↗
EIT Food
2023-04-17 |